Complete Guide to Voriconazole IV Pharmacokinetics
Overview
Voriconazole IV is a Small Molecule used in the Infectious Disease therapeutic area. It is indicated for Invasive Fungal Infections. Population PK simulator for IV voriconazole. Explore loading doses and steady-state trough targets.
Mechanism of Action
Voriconazole IV exerts its pharmacological effect by targeting CYP51. As a Small Molecule, it modulates this target to achieve therapeutic efficacy in Invasive Fungal Infections. Understanding the target engagement is critical for interpreting the pharmacokinetic-pharmacodynamic (PK/PD) relationship and optimizing dosing regimens.
Key Pharmacokinetic Parameters
The following parameters are derived from published PopPK models for Voriconazole IV:
| Parameter | Value |
|---|---|
| Q | 14 L/h |
| CL | 4.6 L/h (70 kg, CYP2C19 EM) |
| Km | 3.0 mg/L (Michaelis-Menten) |
| Vc | 58 L |
| Vp | 98 L |
| Vmax | 18 mg/h |
| t half | 6-12 h (dose-dependent) |
| ka oral | 1.0-2.0 h⁻¹ |
| CYP2C19 effect | PM ~4x higher exposure |
| Ctrough target | 2-5.5 mg/L |
| protein binding | 58% |
| bioavailability oral | 0.96 |
Parameters represent typical population estimates from published literature. Individual values may vary.
Dosing & Administration
Voriconazole IV is administered via the IV route. Intravenous administration provides 100% bioavailability and allows precise control of drug exposure. Infusion duration and rate can significantly impact peak concentrations.
Dosing recommendations should always follow approved prescribing information. The interactive simulator allows you to explore different dosing scenarios and their impact on drug exposure metrics such as AUC, Cmax, and Ctrough.
Clinical Considerations
In the Infectious Disease therapeutic area, for the treatment of Invasive Fungal Infections, understanding the pharmacokinetics of Voriconazole IV is essential for dose optimization and therapeutic drug monitoring. Key clinical factors that may affect Voriconazole IV pharmacokinetics include:
- •Body weight and body composition
- •Renal and hepatic function
- •Drug-drug interactions and concomitant medications
- •Age, sex, and genetic polymorphisms
Interactive Voriconazole IV PK Simulator
Explore Voriconazole IV pharmacokinetics interactively. Adjust doses, dosing intervals, and patient covariates to visualize concentration-time profiles in real time.
Frequently Asked Questions
What is the half-life of Voriconazole IV?
The elimination half-life of Voriconazole IV depends on patient-specific factors. Based on published models, the typical half-life is approximately 6-12 h (dose-dependent).
How is Voriconazole IV administered?
Voriconazole IV is administered via the IV route. It is indicated for Invasive Fungal Infections. As a Small Molecule, dosing regimens should follow approved prescribing information and clinical guidelines.
What are the key PK parameters of Voriconazole IV?
Key pharmacokinetic parameters for Voriconazole IV include clearance (CL), volume of distribution (Vd), and elimination half-life. See the PK Parameters section above for specific values from published models.
Can I simulate Voriconazole IV dosing scenarios for free?
Yes! PKPDBuilder offers a completely free, interactive Voriconazole IV PK simulator based on published pharmacometric models. No login required. Use it to explore different doses, dosing intervals, and patient covariates.
⚠️ Disclaimer
This guide is for research and educational purposes only. It is not intended for clinical decision-making or patient dosing. Parameters are derived from published literature and represent population estimates. Always consult approved prescribing information for clinical use.